As of November 2024 Cynata Therapeutics has 145.09M shares outstanding, a increase of 1.27% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 145.09M | 1.27% |
2022 | 143.28M | 9.85% |
2021 | 130.43M | 24.43% |
2020 | 104.82M | - |